VIVUS, Inc. (VVUS) Posts Q2 Loss of 25c/Share

Go back to VIVUS, Inc. (VVUS) Posts Q2 Loss of 25c/Share

Vivus (VVUS) PT, Qsymia Sales Ramp Assumptions Cut at BofA/Merrill Lynch

August 8, 2014 6:57 AM EDT

BofA/Merrill Lynch analyst Steve Byrne reiterated an Underperform rating and lowered his price target on Vivus (NASDAQ: VVUS) to $4.00 (from $5.00) following Q14 Qsymia revenue of $11 million, in-line with their view.

Byrne notes while an improvement from the $9.1 million in Q1... More